Paper30628811
Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.
Sakloth F and 5 others. Exp Clin Psychopharmacol, 2019. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Papers, record 30628811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30628811
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics, Opioid | Major topic |
| Hallucinogens | Major topic |
| Self Stimulation | Major topic |
| Serotonin 5-HT2 Receptor Agonists | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Male | |
| Medial Forebrain Bundle | |
| Rats | |
| Rats, Sprague-Dawley | |
| Receptor, Serotonin, 5-HT2A | |
| Receptors, Opioid, kappa |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA033930 | NIDA NIH HHS | United States | R01DA033930 | PubMed and NIH | NIH RePORTER |
| T32 DA007027 | NIDA NIH HHS | United States | T32DA007027 | PubMed and NIH | NIH RePORTER |
| National Institutes of Health; National Institute on Drug Abuse | PubMed | PubMed |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,064,726 | Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat. | J Pharmacol Exp Ther | 1976 | https://conductscience.org/library/papers/1064726 | PubMed |
| 2 | 12,213,075 | Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD). | J Med Chem | 2002 | https://conductscience.org/library/papers/12213075 | PubMed |
| 3 | 13,717,955 | Cross tolerance between LSD and psilocybin. | Psychopharmacologia | 1961 | https://conductscience.org/library/papers/13717955 | PubMed |
| 4 | 14,119,492 | PHARMACOLOGICAL PATTERNS IN SUBCORTICAL REINFORCEMENT BEHAVIOR. | Int J Neuropharmacol | 1963 | https://conductscience.org/library/papers/14119492 | PubMed |
| 5 | 14,161,141 | TOLERANCE TO BEHAVIORAL EFFECTS OF LSD-25 IN RAT. | J Pharmacol Exp Ther | 1964 | https://conductscience.org/library/papers/14161141 | PubMed |
| 6 | 14,727,002 | Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/14727002 | PubMed |
| 7 | 15,019,419 | LSD, 5-HT (serotonin), and the evolution of a behavioral assay. | Neurosci Biobehav Rev | 2004 | https://conductscience.org/library/papers/15019419 | PubMed |
| 8 | 15,096,915 | Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. | Behav Pharmacol | 2004 | https://conductscience.org/library/papers/15096915 | PubMed |
| 9 | 17,196,053 | Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. | J Clin Psychiatry | 2006 | https://conductscience.org/library/papers/17196053 | PubMed |
| 10 | 17,695,343 | G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. | Behav Res Methods | 2007 | https://conductscience.org/library/papers/17695343 | PubMed |
| 11 | 17,977,517 | The behavioral pharmacology of hallucinogens. | Biochem Pharmacol | 2008 | https://conductscience.org/library/papers/17977517 | PubMed |
| 12 | 18,007,634 | Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. | Nat Protoc | 2007 | https://conductscience.org/library/papers/18007634 | PubMed |
| 13 | 19,782,055 | Dynorphin, stress, and depression. | Brain Res | 2010 | https://conductscience.org/library/papers/19782055 | PubMed |
| 14 | 20,101,391 | Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. | Psychopharmacology (Berl) | 2010 | https://conductscience.org/library/papers/20101391 | PubMed |
| 15 | 20,493,209 | Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats. | Pharmacol Biochem Behav | 2010 | https://conductscience.org/library/papers/20493209 | PubMed |
| 16 | 20,577,718 | Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine. | Psychopharmacology (Berl) | 2011 | https://conductscience.org/library/papers/20577718 | PubMed |
| 17 | 20,819,978 | Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. | Arch Gen Psychiatry | 2011 | https://conductscience.org/library/papers/20819978 | PubMed |
| 18 | 22,406,913 | Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. | J Psychopharmacol | 2012 | https://conductscience.org/library/papers/22406913 | PubMed |
| 19 | 22,978,626 | Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/22978626 | PubMed |
| 20 | 23,851,484 | Rate-dependent effects of monoamine releasers on intracranial self-stimulation in rats: implications for abuse liability assessment. | Behav Pharmacol | 2013 | https://conductscience.org/library/papers/23851484 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,076,014 | Electrocorticographic Changes and Neuronal Maturation in the Antidepressant-like and Anxiolytic Effects of Micro- or Macrodosing of Psilocybe cubensis Mushroom in Mice. | Molecules | 2026 | https://conductscience.org/library/papers/42076014 | PubMed |
| 41,751,376 | Opioid Receptors in Psychedelia: Indirect Serotonergic Modulation of Direct KOR Activation by Salvinorin A. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751376 | PubMed |
| 41,266,307 | Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward. | Nat Commun | 2025 | https://conductscience.org/library/papers/41266307 | PubMed |
| 40,047,011 | Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents. | Psychedelic Med (New Rochelle) | 2023 | https://conductscience.org/library/papers/40047011 | PubMed |
| 39,467,003 | Preclinical models for evaluating psychedelics in the treatment of major depressive disorder. | Br J Pharmacol | 2026 | https://conductscience.org/library/papers/39467003 | PubMed |
| 39,228,432 | Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets. | Subst Abuse Rehabil | 2024 | https://conductscience.org/library/papers/39228432 | PubMed |
| 38,203,411 | Molecular and Medical Aspects of Psychedelics. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203411 | PubMed |
| 37,999,867 | The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review. | CNS Drugs | 2023 | https://conductscience.org/library/papers/37999867 | PubMed |
| 37,940,583 | Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action. | J Neurosci | 2023 | https://conductscience.org/library/papers/37940583 | PubMed |
| 37,886,350 | Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice. | Front Pain Res (Lausanne) | 2023 | https://conductscience.org/library/papers/37886350 | PubMed |
| 37,886,127 | μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37886127 | PubMed |
| 37,759,040 | Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/37759040 | PubMed |
| 36,272,734 | Effects of 2,5-Dimethoxy-4-Methylamphetamine (DOM) and 2-Piperazin-1-yl-Quinoline (Quipazine) on Fentanyl Versus Food Choice in Rhesus Monkeys. | J Pharmacol Exp Ther | 2023 | https://conductscience.org/library/papers/36272734 | PubMed |
| 36,241,352 | Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial). | BMJ Open | 2022 | https://conductscience.org/library/papers/36241352 | PubMed |
| 36,097,251 | A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. | CNS Drugs | 2022 | https://conductscience.org/library/papers/36097251 | PubMed |
| 35,695,174 | Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice. | J Psychopharmacol | 2022 | https://conductscience.org/library/papers/35695174 | PubMed |
| 35,233,648 | Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. | Psychopharmacology (Berl) | 2022 | https://conductscience.org/library/papers/35233648 | PubMed |
| 34,296,204 | A Strategy to Prioritize Emerging Drugs of Abuse for Analysis: Abuse Liability Testing Using Intracranial Self-Stimulation (ICSS) in Rats and Validation with α-Pyrrolidinohexanophenone (α-PHP). | Emerg Trends Drugs Addict Health | 2021 | https://conductscience.org/library/papers/34296204 | PubMed |
| 32,922,736 | The therapeutic potential of microdosing psychedelics in depression. | Ther Adv Psychopharmacol | 2020 | https://conductscience.org/library/papers/32922736 | PubMed |
| 32,458,577 | Effects of 5-HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self-administration in male rats. | Addict Biol | 2021 | https://conductscience.org/library/papers/32458577 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HTR1A | 3,350 | PubTator's text mining | https://conductscience.org/library/genes/3350 | NCBI Gene |
| HTR2A | 3,356 | PubTator's text mining | https://conductscience.org/library/genes/3356 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30628811
GET https://conductscience.org/api/papers/v1/30628811/references?page=2